QUOTE AND NEWS
Business Wire  Jan 19  Comment 
Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that Tarek Sherif, chairman and chief executive officer, and Bruce Dalziel, chief financial officer, will present at the Jefferies
Motley Fool  Dec 24  Comment 
Pick up great stocks when they're cheap, and you'll win more.
Business Wire  Dec 23  Comment 
Medidata Solutions, Inc., a leading global provider of hosted clinical development solutions, today announced that the underwriters of its secondary offering exercised in full their over-allotment option to purchase an additional 825,000 shares of
Business Wire  Dec 9  Comment 
Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced the pricing of 5,500,000 shares of its common stock at $15.00 per share in a public offering by a number of its stockholders. In
Business Wire  Dec 7  Comment 
Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that inVentiv Clinical Solutions, LLC (inVentiv Clinical), the contract research organization (CRO) division of inVentiv Health
Business Wire  Dec 3  Comment 
Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, announced the introduction of Rave Safety Gateway, the newest extension to its Medidata Rave® electronic data capture (EDC) and clinical data
Business Wire  Nov 30  Comment 
Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that PRA International, a global clinical research organization (CRO), has achieved Rave Accredited Plus status in the ASPire to
StreetInsider.com  Nov 20  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Medidata+Solutions+%28MDSO%29+Announces+4.5M+Common+Offering+by+Selling+Shareholders/5129217.html for the full story.
Business Wire  Nov 20  Comment 
Medidata Solutions, Inc. (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that it filed a registration statement with the Securities and Exchange Commission for a proposed public offering of 4.5
StreetInsider.com  Nov 12  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Medidata+Solutions+%28MDSO%29+Tops+Q3+Views%3B+Guides+Q4%2C+FY09/5103680.html for the full story.



Thank you for your suggestion
 
TOP CONTRIBUTORS


Medidata Solutions (NASDAQ:MDSO) sells a software platform called Medidata Rave that helps biotech and pharmaceutical companies enhance the efficiency of their clinical development processes.[1] It achieves this by integrating electronic data capture (EDC) with a clinical data management system (CDMS) in a single product.
Medidata Rave is a comprehensive platform that replaces traditional paper-based methods of capturing and managing clinical data.
Medidata Rave is a comprehensive platform that replaces traditional paper-based methods of capturing and managing clinical data.
The company also sells a protocol authoring tool (Medidata Designer), a grant management system (Medidata Grant Manager) and a CRO contracting platform (Medidata CRO Contractor). In 2007, 2008 and the first quarter of 2009, the company's top five customers by revenue were Johnson & Johnson, AstraZeneca, Amgen, Astellas Pharma and Takeda Pharmaceutical.[1]

Medidata's initial public offering (IPO) of stock is scheduled for 18 June 2009. It plans to sell 6.3 million shares at between $11 and $12 per share. In 2008, the company had $106 million in total revenues, up 67.9% from $63.0 million in 2007. However, it still made a net loss of $18.3 million, down 22.8% from the $23.7 million net loss made in 2007.[2] In the same year, 69% of revenues came from customers in the United States, 21% from Europe and 10% from Asia (including Australia). In the first quarter of 2009, the company had $33.6 million in total revenues, up 60.2% from $21.0 million in the same quarter of the 2008.[2] It also had $1.7 million in net income, up 120% from the $8.6 million net loss made in 2007. Existing investors in the company include Insight Venture Partners (33.9%), chief executive officer and chairman Tarek Sherif (9.0%), president and director Glen M. de Vries (9.0%) and Milestone Venture Partners (7.6%).

References

  1. 1.0 1.1 Business, 2009 MDSO S-1/A
  2. 2.0 2.1 Selected Consolidated Financial Information, 2009 MDSO S-1/A
Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki